Free Trial

Jazz Pharmaceuticals (JAZZ) Earnings Date, Estimates & Call Transcripts

Jazz Pharmaceuticals logo
$125.10 +5.86 (+4.91%)
(As of 11/21/2024 ET)
Get Jazz Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jazz Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

JAZZ Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

JAZZ Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Jazz Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$3.24$3.60$3.42 
Q2 20242$3.68$4.23$3.96 
Q3 20242$4.34$4.52$4.43 
Q4 20241$4.83$4.83$4.83 
FY 20247$16.09$17.18$16.64 
Q1 20251$3.13$3.13$3.13 
Q2 20251$4.09$4.09$4.09 
Q3 20251$4.35$4.35$4.35 
Q4 20251$4.55$4.55$4.55 
FY 20254$16.12$16.12$16.12 
Q1 20261$3.77$3.77$3.77 
Q2 20261$4.33$4.33$4.33 
Q3 20261$4.67$4.67$4.67 

Jazz Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/26/2025
(Estimated)
------- 
7/31/2024Q2 2024$3.80$4.67+$0.87$6.85$1.00B$1.02B
5/1/2024Q1 2024$3.53$1.98 -$1.55$4.19$938.99M$901.98M    
2/28/2024Q4 2023$4.44$4.40 -$0.04$7.38$1.01B$1.01B        
11/8/2023Q3 2023$4.21$4.22+$0.01$6.30$969.47M$972.14M    
8/9/2023Q2 2023$3.68$3.83+$0.15$6.14$952.44M$957.32M    
5/10/2023Q1 2023$3.58$3.20 -$0.38$5.36$898.11M$892.81M    
3/1/2023Q4 2022--$0.84 -$0.84$2.14$972.70M$972.12M    

Jazz Pharmaceuticals Earnings - Frequently Asked Questions

Jazz Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates. Learn more on JAZZ's earnings history.

Jazz Pharmaceuticals issued an update on its FY 2024 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of 19.500-20.600 for the period, compared to the consensus estimate of 19.590. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded annual revenue of $3.83 billion.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded net income of $414.83 million. JAZZ has generated $7.10 earnings per share over the last four quarters.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a trailing price-to-earnings ratio of 17.62 and a forward price-to-earnings ratio of 7.33. The price/earnings-to-growth ratio is 0.98.

Jazz Pharmaceuticals's earnings are expected to grow from $17.07 per share to $18.74 per share in the next year, which is a 9.78% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:JAZZ) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners